KUTOK JEFFERY (Chief Scientific Officer) sold 2.8% of their position (2.74K shares) of EPIZYME, INC. on the open market
Open‑market sale worth $2.5K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 4/13/2022ACC: 0000899243-22-014724
Officer· Chief Scientific Officer
Since Apr 2020
-2.74K
Net shares
Net seller
$2.5K
Total sold
1
Open market trades
0B · 1S
1
Total transactions
2.74K disposed
Non-Derivative Transactions1
Common Stock, par value $0.0001
Direct
Shares
−2.74K
Price / share
$0.90
Trade value
$2.47K
% of position
2.8%
4/11/2022
97.30K→94.56K
Total
Net shares
−2.74K
Net value
-$2.47K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock, par value $0.0001 Direct | 4/11/2022 | S · Sale | −2.74K | $0.90 | $2.47K | 2.8% | 97.30K | 94.56K |
| Total | −2.74K | -$2.47K | ||||||
Derivative Transactions0
No derivative transactions reported